14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for BPTH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.93 12.26 %
R2 2.83 8.31 %
R1 2.76 5.87 %
Current price: 2.61
Support S1 2.56 -2.04 %
S2 2.49 -4.48 %
S3 2.39 -8.43 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.24 24.14 %
R2 2.92 11.88 %
R1 2.69 2.87 %
Current price 2.61
Support S1 2.49 -4.60%
S2 0 .
S3 0 .

BPTH Predictions History

5 years ago
JS predicted that BPTH for 2019-03-15 is going $25.22 (-14.22%)

5 years ago
PumpTheseNumbers predicted that BPTH for 2019-03-14 is going $32.58 (18.60%)

5 years ago
JS predicted that BPTH for 2019-03-14 is going $27.62 (0.55%)

5 years ago
Sergiu predicted that BPTH for 2019-03-14 is going $25.09 (-8.66%)

Rank:

5 years ago
JS predicted that BPTH for 2019-03-12 is going $31.22 (-11.13%)

5 years ago
Sergiu predicted that BPTH for 2019-03-12 is going $35.12 (-0.03%)

Rank:

5 years ago
PumpTheseNumbers predicted that BPTH for 2019-03-07 is going $10.91 (-71.92%)

5 years ago
JS predicted that BPTH for 2019-03-07 is going $11.37 (-70.74%)

5 years ago
Gp predicted that BPTH for 2019-03-07 is going $10.84 (-72.10%)

5 years ago
PumpTheseNumbers predicted that BPTH for 2019-02-08 is going $2.13 (2.90%)

Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT